BCR-ABL1 Quantitative p210p190p230
Introduction
The BCR-ABL1 Quantitative p210p190p230 test is a critical diagnostic tool used in the evaluation and monitoring of patients with certain types of leukemia, specifically Chronic Myeloid Leukemia (CML) and Acute Lymphoblastic Leukemia (ALL). This test quantifies the levels of BCR-ABL1 fusion gene transcripts in the blood or bone marrow, providing essential information about the disease’s progression and response to treatment.
What Does the Test Measure?
This test measures the quantity of BCR-ABL1 fusion proteins, which are produced when parts of two chromosomes (9 and 22) break off and reattach incorrectly. The presence of these proteins indicates the presence of leukemia, and their levels can help determine how well a patient is responding to therapy.
Who Should Consider This Test?
Patients experiencing symptoms of leukemia, such as fatigue, unexplained weight loss, or frequent infections, should consider this test. Additionally, individuals with risk factors, including a family history of leukemia or previous exposure to certain chemicals or radiation, may also benefit from testing.
Benefits of Taking the Test
- Early detection of leukemia, allowing for timely intervention.
- Monitoring treatment effectiveness and disease progression.
- Guiding treatment decisions based on the quantification of BCR-ABL1 levels.
- Providing reassurance to patients and their families regarding health status.
Understanding Your Results
Results from the BCR-ABL1 Quantitative test will indicate the level of BCR-ABL1 transcripts present. A higher level may suggest disease progression, while a decrease may indicate a positive response to treatment. Your healthcare provider will help interpret the results and discuss the next steps.
Test Details and Pricing
| Test Name | Discount Price | Regular Price |
|---|---|---|
| BCR-ABL1 Quantitative p210p190p230 | 18000 KSh | 24000 KSh |
Additional Information
Turnaround time for results is typically 3-4 days. The test requires a sample of bone marrow or peripheral blood, which should be transported immediately to the lab for accurate results. It is important to note that a doctor’s prescription is needed to conduct this test. However, a prescription is not applicable for surgery and pregnancy cases or individuals planning to travel abroad.
Book Your Test Today!
We have branches across all major cities in Kenya, including Nairobi, Mombasa, and Kisumu. For your convenience, we also offer home sample collection services. To book the BCR-ABL1 Quantitative p210p190p230 test, please call or WhatsApp us at +254711564616.
